Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Microlax®:Janssen-Cilag AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
A06AG11 - Sodium Lauryl Sulfoacetate, incl. CombinationsATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
A06 - Drugs for Constipation
A06A - Drugs for Constipation

All agents used for treatment of constipation (regardless of indication) are classified here.
The agents are mainly subdivided according to mode of action. All enemas are classified in A06AG, regardless of mode of action.
Some combination products are classified at separate levels. These are mentioned in the respective ATC group.
Otherwise combination products are classified at separate 5th levels using the corresponding 50-series.
Laxatives in combination with centrally acting antiobesity agents are classified in A08A - Antiobesity preparations, excl. diet products.

A06AG - Enemas

All enemas and laxative rectal solutions are classified in this group, regardless of mode of action.
Combined packages containing tablets and enemas are classified in this group.
Some 5th levels for plain substances also include combinations, e.g.:
A06AG10 - docusate sodium- and e.g. sorbitol or glycerol
A06AG11 - sodium lauryl sulfoacetate and e.g. sodium citrate
Sodium laurilsulfate is also classified in A06AG11.

The DDDs for enemas classified in this group are 1 enema.

A06AG11 - Sodium Lauryl Sulfoacetate, incl. Combinations
2020 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home